ProBiotix Health Plc (AQU:PBX)

London · Delayed Price · Currency is GBP · Price in GBX

10.50

0.00 (0.00%)

At close: Sep 1, 2026

16.67% (1Y)

Market Cap	16.61M +16.7%
Revenue (ttm)	2.73M +45.1%
Net Income	-1.23M
EPS	-0.01
Shares Out	158.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	10.50
Day's Range	n/a
52-Week Range	5.75 - 10.50
Beta	0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About ProBiotix Health

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. The company offers YourBiotixMH for menopause health; YourBiotixCH InstaMelt and YourBiotixCH for cholesterol maintenance; and YourBiotixX3 for cholesterol reduction. It also provides YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in Fe... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2012

Employees 12

Stock Exchange Aquis Exchange

Ticker Symbol PBX

Full Company Profile

Financial Performance

In 2025, ProBiotix Health's revenue was 2.73 million, an increase of 45.09% compared to the previous year's 1.88 million. Losses were -1.23 million, 45.6% more than in 2024.

Financial Statements